Early detection of psoriatic arthritis in patients with psoriasis: construction of a multifactorial prediction model

Chunxiao Wang1,2, Sihan Wang1,2, Liu Liu1,2

  • 1Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Frontiers in Immunology
|December 26, 2024
PubMed

Insights

Psoriatic arthritis (PsA) risk in psoriasis patients can be predicted using six key factors. A new calculator helps clinicians identify those needing early intervention for better outcomes.

Area of Science:

  • Rheumatology
  • Dermatology
  • Clinical Prediction Modeling

Background:

  • Psoriatic arthritis (PsA) affects a significant portion of psoriasis patients.
  • Early identification of PsA risk is vital for preventing poor prognosis.
  • Predictive models can aid in timely clinical decision-making.

Purpose of the Study:

  • To develop and validate a predictive model for identifying psoriasis patients at high risk of developing PsA.
  • To create a user-friendly web-based calculator for clinical application.

Main Methods:

  • A derivation cohort of 1,661 psoriasis patients was analyzed.
  • Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression were used for variable selection.
  • A web-based calculator was developed based on the identified predictors.

Main Results:

  • Six independent predictors for PsA development were identified: unexplained swollen joints, history of arthritis, swollen/painful digits, nail involvement, hyperlipidemia, and prolonged topical glucocorticosteroid use.
  • Odds ratios and confidence intervals were calculated for each predictor.
  • A web-based calculator was created to estimate PsA probability.

Conclusions:

  • The developed prediction model and calculator can assist clinicians in identifying psoriasis patients at risk for PsA.
  • Early risk assessment facilitates prompt intervention and potentially improves patient prognosis.
  • This tool supports evidence-based clinical decision-making in managing psoriasis patients.